Avorn J, Soumerai S B, Everitt D E, Ross-Degnan D, Beers M H, Sherman D, Salem-Schatz S R, Fields D
Program for the Analysis of Clinical Strategies, Harvard Medical School, Boston, MA.
N Engl J Med. 1992 Jul 16;327(3):168-73. doi: 10.1056/NEJM199207163270306.
Although psychoactive medications have substantial side effects in the elderly, these drugs are used frequently in nursing homes. Few interventions have succeeded in changing this situation, and little is known about the clinical effects of such interventions.
We studied six matched pairs of nursing homes; at one randomly selected nursing home in each pair, physicians, nurses, and aides participated in an educational program in geriatric psychopharmacology. At base line we determined the type and quantity of drugs received by all residents (n = 823), and a blinded observer performed standardized clinical assessments of the residents who were taking psychoactive medications. After the five-month program, drug use and patient status were reassessed.
Scores on an index of psychoactive-drug use, measuring both the magnitude and the probable inappropriateness of medication use, declined significantly more in the nursing homes in which the program was carried out (experimental nursing homes) than in the control nursing homes (decrease, 27 percent vs. 8 percent; P = 0.02). The use of antipsychotic drugs was discontinued in more residents in the experimental nursing homes than in the control nursing homes (32 percent vs. 14 percent); the comparable figures for the discontinuation of long-acting benzodiazepines were 20 percent vs. 9 percent, and for antihistamine hypnotics, 45 percent vs. 21 percent. In the experimental nursing homes residents who were initially taking antipsychotic drugs showed less deterioration on several measures of cognitive function than similar residents in the control facilities, but they were more likely to report depression. Those who were initially taking benzodiazepines or antihistamine hypnotic agents reported less anxiety than controls but had more loss of memory. Most other measures of clinical status remained unchanged in both groups.
An educational program targeted to physicians, nurses, and aides can reduce the use of psychoactive drugs in nursing homes without adversely affecting the overall behavior and level of functioning of the residents.
尽管精神活性药物在老年人中具有显著的副作用,但这些药物在养老院中却经常被使用。很少有干预措施成功改变这种状况,而且对于此类干预措施的临床效果知之甚少。
我们研究了六对匹配的养老院;在每对中随机选择的一家养老院里,医生、护士和护理员参加了老年精神药理学方面的教育项目。在基线期,我们确定了所有居民(n = 823)所服用药物的类型和数量,并且一名盲法观察者对正在服用精神活性药物的居民进行了标准化的临床评估。在为期五个月的项目结束后,重新评估了药物使用情况和患者状况。
衡量药物使用量及可能不适当性的精神活性药物使用指数得分,在实施该项目的养老院(实验性养老院)中下降幅度明显大于对照养老院(下降幅度分别为27%和8%;P = 0.02)。与对照养老院相比,实验性养老院中有更多居民停用了抗精神病药物(32%对14%);长效苯二氮䓬类药物停用的相应比例为20%对9%,抗组胺催眠药为45%对21%。在实验性养老院中,最初服用抗精神病药物的居民在几项认知功能指标上的恶化程度低于对照机构中的类似居民,但他们更有可能报告有抑郁情绪。最初服用苯二氮䓬类药物或抗组胺催眠药的居民报告的焦虑情绪比对照组少,但记忆力丧失更多。两组中大多数其他临床状况指标保持不变。
针对医生、护士和护理员的教育项目可以减少养老院中精神活性药物的使用,而不会对居民的总体行为和功能水平产生不利影响。